Thrombosis Risk Factors
Study data from University of Murcia provide new insights into thrombosis risk factors
Published in Drug Week, June 22nd, 2007
New research, "Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis," is the subject of a report. According to a study from Murcia, Spain, "The antithrombin A384S mutation has a relatively high frequency in the British population but has not been identified in other populations. This variant has been associated with cases of thrombotic disease, but its clinical relevance in venous thrombosis remained unclear."
"We have conducted a secondary analysis of the prevalence of the mutation in a large case-control study, including 1018 consecutive Spanish patients with venous thromboembolism. In addition, we evaluated its functional...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-06-22)
More Articles from Drug Week
- Aging
Dietary Preferences and Patterns May Be Linked to Genes - Angiogenesis
Molecular Markers Predict Tumor Recurrence - Angiology
FDA Approves Ostial Pro Stent Positioning System - Angioplasty
Coronary Stents: Overview of This Common Tool to Keep Clogged Arteries Open - Arthritis
University of Manchester researchers reveal clues to new genes behind rheumatoid arthritis - Breast Cancer
Brain-boosting pill alleviates post-chemotherapy fogginess - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
